S. Gail Eckhardt, M.D.

S. Gail Eckhardt, M.D.

Independent DirectoratExelixis· In proxies 2023–2025

S. Gail Eckhardt, M.D. sits on 3 public boards.

Experience

  1. ExelixisPublic company · 3 yr
    • Independent Director2023 – Present · 3 yrStock in role +258%
  2. Amgen Inc., serving on the Scientific Advisory Board (Oncology)Public company
    • Director? – PresentNo stock prices for these years
  3. Syros Pharmaceuticals, Inc., serving on the CompensationPublic company
    • Director? – PresentNo stock prices for these years
  4. Syros Pharmaceuticals, Inc.Public company · 4 yr
    • Director2020 – 2024 · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?